# BYFAVO
> **NDA212295** · New Drug Application · Sponsor: ACACIA · Approved 2020-07-02
## Drug
- **FDA Application Number:** NDA212295
- **Application type:** New Drug Application
- **Brand name:** BYFAVO
- **Generic name:** REMIMAZOLAM BESYLATE
- **Active ingredients:** REMIMAZOLAM BESYLATE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ACACIA
- **Manufacturer:** Acacia Pharma, Ltd.
- **First approval:** 2020-07-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212295)
---
*MORVS · CC0 1.0*